Sangamo BioSciences | Lånekapital

Loan Capital Endring Dato
Bayer EUR 35.11B 1.45B 2023-09
Clal Biotechnology ILS 7.49M 405K 2022-12
Compugen USD 0 0 2022-06
CSL USD 11.17B 269.8M 2023-06
Gilead Sciences USD 23.19B 1.98B 2023-09
Grifols EUR 10.3B 926.47M 2023-09
Roche Holding CHF 20.35B 1.05B 2023-06
Ultragenyx Pharmaceutical USD 0 0 2022-06



Sangamo BioSciences Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.